Skip to main content
. 2015 May-Jun;20(3):186–196. doi: 10.5863/1551-6776-20.3.186

Table 3.

Top Medications Used Off-Label in the Pediatric Intensive Care Unit (PICU) and Suggested Prioritization Based on High Off-Label Use (Off Label Use in at Least 5% of the Cohort), High Risk Status (As Identified by the Institute of Safe Medication Practices) and High Regulatory Priority (As Identified by Either the US Food and Drug Administration or Through the Efforts Under the Best Pharmaceuticals for Children Act [BPCA])

graphic file with name i1551-6776-20-3-186-t02.jpg